HIGHFDA DRUG

Meclizine Hydrochloride Tablets Recalled for Failed Specifications (2026) 697 Cartons Nationwide

Meclizine Hydrochloride Tablets distributed nationwide by Amerisource Health Services LLC are being recalled. The two affected NDCs are 60687-775-65 and 60687-775-11. The recall is due to failed tablet specifications. Stop using the product and contact a healthcare provider for guidance immediately.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
March 16, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
March 16, 2026
Hazard Level
HIGH
Brands
MECLIZINE HYDROCHLORIDE, American Health Packaging
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
MECLIZINE HYDROCHLORIDE, American Health Packaging
Product type
Meclizine Hydrochloride Tablets 12.5 mg
Model numbers
Lot #1024852, Exp 9/30/2026
UPC codes
60687-730, 60687-775, 60687-775-11, 60687-775-01, 60687-775-65, 60687-730-11, 60687-730-01, 60687-730-65
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    March 16, 2026

  2. Reported by FDA DRUG

    April 1, 2026

  3. RecallRadar source check

    April 8, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed tablet specifications.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amerisource Health Services LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Meclizine is used to prevent and treat nausea, vomiting, and motion sickness. The 12.5 mg tablet is a common dose for adults for short-term relief.

Why This Is Dangerous

A failure to meet tablet specifications can lead to incorrect dosage, which may affect safety and efficacy.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

Consumers with the affected lots may face dosing uncertainty. The recall is active and distributed nationwide.

Practical Guidance

How to identify if yours is affected

  1. Review NDC numbers on the bottle: 60687-775-65 and 60687-775-11.
  2. Check lot number 1024852 and expiration date 9/30/2026.
  3. Verify distributor: Amerisource Health Services LLC.

Where to find product info

FDA enforcement page and recall notice linked to the NDCs and lot numbers.

What timeline to expect

Recall notice indicates a letter will be issued with next steps. Specific refund timelines are not provided.

If the manufacturer is unresponsive

  • File a consumer complaint with the FDA if the sponsor is unresponsive.
  • Consult your pharmacist or healthcare provider for guidance.

How to prevent similar issues

  • Check NDCs and lot numbers before purchasing medications.
  • Buy from reputable pharmacies and verify packaging integrity.
  • Keep all recall notices for reference.

Documentation advice

Keep the recall letter, packaging, and any correspondence with the pharmacy or provider. Photograph the product and packaging for records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

NDC 60687-775-65: 50 Tablets per carton [5 x 10], Rx Only, 697 cartons distributed nationwide in the U.S. NDC 60687-775-11: 12.5 mg Individual Dose, Rx Only, 697 cartons distributed nationwide. Distributor: Amerisource Health Services LLC, Columbus, OH 43217. Recall date: 2026-03-16. Status: Active. Manufactured by Meclizine Hydrochloride supplier. The package form includes both multi-dose cartons and single-dose units.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 697 cartons recalled nationwide
  • Distributor: Amerisource Health Services LLC

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot #1024852
Exp 9/30/2026
UPC Codes
60687-730
60687-775
60687-775-11
+5 more
Affected States
ALL
Report Date
April 1, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

KVK-Tech Inc. Recalls Oxycodone Hydrochloride Tablets Over Seal Defects

KVK-Tech Inc. recalled 31,676 packages of Oxycodone Hydrochloride Tablets on January 14, 2026. Defective seals may cause tablets to fall out, posing a health risk. Customers should stop using the product immediately and seek guidance from healthcare providers.

OXYCODONE HYDROCHLORIDE
Defective container:
Read more